Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
Open-market buys, last 90 days
$34,349
in 1 filing
Open-market sales, last 90 days
$296,397
in 5 filings

Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2012-05-16 Ayer Capital Management, LP 10% owner Sale −140,300 $0.67 $94K 2,617,320
2012-05-15 Ayer Capital Management, LP 10% owner Sale −1,000 $0.85 $850 2,757,620
2012-03-22 THOMPSON STEPHEN B CFO Other disposition · Stock option (right to buy) −6,000 $18.65 $112K 437,000
2012-03-22 NOWOTNIK DAVID P Sr. VP R&D Other disposition · Stock option (right to buy) −10,000 $18.65 $187K 545,000
2012-01-23 Howell Stephen B. Director Grant or award +300 495
2012-01-23 THOMPSON STEPHEN B CFO Grant or award +15,000 $1.36 $20K 18,521
2012-01-23 NOWOTNIK DAVID P Sr. VP R&D Grant or award +15,000 $1.36 $20K 20,116
2011-05-26 Howell Stephen B. Director Grant or award · Stock Option (right to buy) +700 700
2011-05-26 NOWOTNIK DAVID P Sr. VP R&D Grant or award · Stock option (right to buy) +12,500 $2.27 $28K 467,500
2011-05-26 NOWOTNIK DAVID P Sr. VP R&D Grant or award · Stock option (right to buy) +37,500 $2.27 $85K 505,000
2011-05-26 THOMPSON STEPHEN B CFO Grant or award · Stock option (right to buy) +12,500 $2.27 $28K 355,500
2011-05-26 THOMPSON STEPHEN B CFO Grant or award · Stock option (right to buy) +37,500 $2.27 $85K 393,000
2010-05-26 Howell Stephen B. Director Grant or award · Stock Option (right to buy) +600 600
2010-05-26 THOMPSON STEPHEN B CFO Grant or award · Stock option (right to buy) +100,000 $2.45 $245K 343,000
2010-02-01 NOWOTNIK DAVID P Sr VP R&D Grant or award · Stock option (right to buy) +200,000 $2.79 $558K 455,000
2009-06-01 LUCI DAVID P Director Grant or award +200,000 263,217
2009-05-27 Howell Stephen B. Director Grant or award · Stock Option (right to buy) +500 500
2009-05-27 Howell Stephen B. Director Grant or award · Stock Option (right to buy) +200 200
2009-05-27 LUCI DAVID P Director Grant or award · Stock option (right to buy) +25,000 $1.38 $35K 68,500
2009-05-27 LUCI DAVID P Director Grant or award · Stock option (right to buy) +20,000 $1.38 $28K 88,500

Page 26 of 34 · 664 trades